Acute ascending muscle weakness secondary to medication-induced hyperkalemia.
Secondary hyperkalemic paralysis is an uncommon but potentially life-threatening consequence of drug-induced disease. We report a case of a 53-year-old female with history of chronic kidney disease presenting to the emergency department with a one-day history of upper and lower extremity weakness and paresthesias. Serum potassium concentration on admission was greater than 8 mEq/L, and serum creatinine was elevated above baseline. Electrocardiogram showed first-degree atrioventricular block with peaked T waves. The patient reported compliance with daily lisinopril 10 mg, spironolactone 25 mg, and 40 mEq twice daily of potassium chloride. Symptoms and electrocardiogram returned to baseline within 24 hours of presentation and serum potassium returned to 4.2 mEq/L at approximately 36 hours without the need for dialysis. This case emphasizes the importance of including such a condition in the differential diagnosis of patients with ascending paralysis and the importance of close monitoring of patients placed on potassium-elevating agents.
University of Tennessee College of Pharmacy and Department of Pharmacy, Methodist University Hospital, 1265 Union Avenue, Thomas Ground-Pharmacy Administration, Memphis, TN 38104, USA.
Lauren A
LA
Kimmons
University of Tennessee College of Pharmacy and Department of Pharmacy, Methodist University Hospital, 1265 Union Avenue, Thomas Ground-Pharmacy Administration, Memphis, TN 38104, USA.
Justin B
JB
Usery